JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
XHYE
5001
DELISTED
BondBloxx USD High Yield Bond Energy Sector ETF
XHYE
| $359K | ﹤0.01% |
9,293
-784
| -8% | -$30.5K |
2024 Q2
2 quarters
|
|
5002
PUT
Valaris
VAL
$5.44B
| $358K | ﹤0.01% |
+8,100
| New | +$390K |
2024 Q4
0 quarters
|
|
|
AFCG
5003
AFC Gamma
AFCG
$78.6M
| $358K | ﹤0.01% |
42,982
+35,204
| +453% | +$338K |
2021 Q2
14 quarters
|
|
|
SMC
5004
Summit Midstream
SMC
$425M
| $357K | ﹤0.01% |
+9,461
| New | +$340K |
2024 Q4
0 quarters
|
|
|
INZY
5005
DELISTED
Inozyme Pharma
INZY
| $357K | ﹤0.01% |
128,872
+99,944
| +345% | +$380K |
2020 Q3
17 quarters
|
|
5006
AlTi Global
ALTI
$335M
| $357K | ﹤0.01% |
80,939
+53,847
| +199% | +$228K |
2023 Q2
6 quarters
|
|
|
FRGE
5007
DELISTED
Forge Global Holdings
FRGE
| $355K | ﹤0.01% |
25,454
+19,683
| +341% | +$324K |
2023 Q1
7 quarters
|
|
5008
Invesco Pharmaceuticals ETF
PJP
$542M
| $355K | ﹤0.01% |
4,301
+255
| +6% | +$21.9K |
2023 Q2
6 quarters
|
|
5009
LXP Industrial Trust 6.5% Series C Preferred Stock
LXP.PRC
$95.5M
| $355K | ﹤0.01% |
7,276
+7,198
| +9,228% | +$365K |
2021 Q4
12 quarters
|
|
5010
ACM Research
ACMR
$5.81B
| $354K | ﹤0.01% |
23,474
-110,697
| -83% | -$2M |
2020 Q2
18 quarters
|
|
|
CUK
5011
DELISTED
Carnival PLC
CUK
| $354K | ﹤0.01% |
15,730
+15,600
| +12,000% | +$331K |
2015 Q1
39 quarters
|
|
5012
Ispire Technology
ISPR
$79.7M
| $354K | ﹤0.01% |
70,375
+47,402
| +206% | +$290K |
2023 Q2
6 quarters
|
|
5013
Methanex
MEOH
$4.52B
| $353K | ﹤0.01% |
7,075
-10,530
| -60% | -$463K |
2015 Q2
38 quarters
|
|
5014
Grupo Aeroportuario del Pacifico
PAC
$12B
| $353K | ﹤0.01% |
2,017
-141
| -7% | -$25.3K |
2015 Q2
38 quarters
|
|
5015
Sibanye-Stillwater
SBSW
$7.05B
| $351K | ﹤0.01% |
106,489
+78,745
| +284% | +$331K |
2013 Q2
46 quarters
|
|
5016
Fidelity Small-Mid Multifactor ETF
FSMD
$2.53B
| $348K | ﹤0.01% |
8,454
+1,506
| +22% | +$64K |
2023 Q2
6 quarters
|
|
|
ASPCU
5017
A SPAC III Acquisition Corp Unit
ASPCU
| $347K | ﹤0.01% |
+34,500
| New | +$346K |
2024 Q4
0 quarters
|
|
5018
CALL
Logitech
LOGI
$14.9B
| $346K | ﹤0.01% |
4,200
-40,000
| -90% | -$3.32M |
2024 Q2
2 quarters
|
|
5019
Dimensional Global Credit ETF
DGCB
$1.1B
| $346K | ﹤0.01% |
6,571
+113
| +2% | +$6.07K |
2024 Q2
2 quarters
|
|
5020
Northern Trust Morningstar US Market Factor Tilt ETF
TILT
$2.2B
| $346K | ﹤0.01% |
1,600
-204
| -11% | -$44.7K |
2021 Q1
15 quarters
|
|
5021
MarineMax
HZO
$1.16B
| $345K | ﹤0.01% |
11,924
+219
| +2% | +$6.72K |
2017 Q4
28 quarters
|
|
5022
Caesarstone
CSTE
$99.2M
| $345K | ﹤0.01% |
81,088
+40,291
| +99% | +$177K |
2013 Q2
46 quarters
|
|
5023
Smith & Nephew
SNN
$11.1B
| $345K | ﹤0.01% |
14,020
-18,957
| -57% | -$503K |
2014 Q2
42 quarters
|
|
|
ZYXI
5024
DELISTED
Zynex
ZYXI
| $344K | ﹤0.01% |
42,997
+2,012
| +5% | +$16.6K |
2019 Q1
23 quarters
|
|
5025
Kornit Digital
KRNT
$751M
| $344K | ﹤0.01% |
11,125
-12,654
| -53% | -$363K |
2020 Q1
19 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.